Skip to main content

Walleye Capital LLC

Position in IRWD — Ironwood Pharmaceuticals Inc

CIK 1758720 NEW YORK, NY

Position in IRWD

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$790,227
-$988,917 QoQ
Shares Held
225,136
-57.4% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IRWD Over Time

Shares Held

Position Value (USD)

Derivatives in IRWD

reported options exposure · as of Mar 31, 2026
CallValue
$30,888
CallShares
8,800
PutValue
$351
PutShares
100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Walleye Capital LLC holds $49,633,459 across 26 Drug Manufacturers - Specialty & Generic names. IRWD ranks #12 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IRWD

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $30,888 8,800
2026-03-31 $790,227 225,136
2026-03-31 $351 100
2025-12-31 $1,779,144 527,936
2025-03-31 $634,172 431,410
2024-12-31 $2,569,829 580,097
2024-09-30 $1,154,831 280,299
2024-06-30 $501,831 76,968
2024-03-31 $89,591 10,286
2023-09-30 $1,607,901 166,968